Ginkgo Bioworks, the Boston-based startup working with DARPA and others on wild science projects involving bio-organisms, has just raised $9 Million in Series A Financing from Felicis Ventures, OS Fund, Data Collective, iGlobe Partners and Vast Ventures.
Ginkgo Bioworks specializes in engineering microbes to produce cultured ingredients, such as flavors, fragrances, cosmetics, and sweeteners.
Silicon Valley investors first took note of the company after it became the first biotech startup to go through Y Combinator in last year’s summer class. But DARPA and other research agencies had already committed to about $15 million in contract work before that.
This raise is more of a strategic play for Ginkgo, according to co-founder Jason Kelly. The company was founded in 2008, but it has started making connections within the tech community since launching out of YC. “We had a huge amount of interest coming out of YC…
View original post 213 more words